PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 102 filers reported holding PULMONX CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,388,000 | +14.1% | 1,223,754 | +0.8% | 0.28% | +14.1% |
| Q2 2022 | $17,873,000 | -32.9% | 1,214,204 | +13.1% | 0.25% | -16.7% |
| Q1 2022 | $26,644,000 | -33.8% | 1,073,904 | -14.4% | 0.30% | -16.2% |
| Q4 2021 | $40,251,000 | -12.1% | 1,255,100 | -1.4% | 0.36% | -10.8% |
| Q3 2021 | $45,796,000 | +59.4% | 1,272,830 | +95.5% | 0.40% | +70.2% |
| Q2 2021 | $28,727,000 | +78.4% | 651,110 | +85.0% | 0.24% | +70.3% |
| Q1 2021 | $16,100,000 | -27.4% | 352,000 | +9.5% | 0.14% | -23.3% |
| Q4 2020 | $22,183,000 | – | 321,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |